The Morningside companies acquired – creating a united business with a combined portfolio of 250+ niche generics

September 25, 2025
The Morningside companies acquired – creating a united business with a combined portfolio of 250+ niche generics

Global licensing agreement for Retinol owned by Orphanix GmbH

Related Articles

Acquisitions

February 11, 2026

Aspire Pharma Strengthens European Footprint with Caragen Acquisition

Read Article
News

October 16, 2025

Medicines Optimisation Centricity – Reimagining Value in the Patient Pathway

Read Article
Acquisitions

October 18, 2025

Acquisition Strengthens Aspire Pharma’s Strategic Portfolio

Read Article
H.I.G. Capital acquires a majority stake in AspireAcquisition of assets from Canute Pharma Ltd